Your browser doesn't support javascript.
loading
Stimuli-sensitive polymer prodrug nanocarriers by reversible-deactivation radical polymerization.
Guerassimoff, Léa; Ferrere, Marianne; Bossion, Amaury; Nicolas, Julien.
Afiliación
  • Guerassimoff L; Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400, Orsay, France. julien.nicolas@universite-paris-saclay.fr.
  • Ferrere M; Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400, Orsay, France. julien.nicolas@universite-paris-saclay.fr.
  • Bossion A; Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400, Orsay, France. julien.nicolas@universite-paris-saclay.fr.
  • Nicolas J; Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400, Orsay, France. julien.nicolas@universite-paris-saclay.fr.
Chem Soc Rev ; 53(12): 6511-6567, 2024 Jun 17.
Article en En | MEDLINE | ID: mdl-38775004
ABSTRACT
Polymer prodrugs are based on the covalent linkage of therapeutic molecules to a polymer structure which avoids the problems and limitations commonly encountered with traditional drug-loaded nanocarriers in which drugs are just physically entrapped (e.g., burst release, poor drug loadings). In the past few years, reversible-deactivation radical polymerization (RDRP) techniques have been extensively used to design tailor-made polymer prodrug nanocarriers. This synthesis strategy has received a lot of attention due to the possibility of fine tuning their structural parameters (e.g., polymer nature and macromolecular characteristics, linker nature, physico-chemical properties, functionalization, etc.), to achieve optimized drug delivery and therapeutic efficacy. In particular, adjusting the nature of the drug-polymer linker has enabled the easy synthesis of stimuli-responsive polymer prodrugs for efficient spatiotemporal drug release. In this context, this review article will give an overview of the different stimuli-sensitive polymer prodrug structures designed by RDRP techniques, with a strong focus on the synthesis strategies, the macromolecular architectures and in particular the drug-polymer linker, which governs the drug release kinetics and eventually the therapeutic effect. Their biological evaluations will also be discussed.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Profármacos / Polimerizacion Idioma: En Revista: Chem Soc Rev Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Profármacos / Polimerizacion Idioma: En Revista: Chem Soc Rev Año: 2024 Tipo del documento: Article